Recruiting
Phase 1
Phase 2

MDX2001

Sponsor:

ModeX Therapeutics, An OPKO Health Company

Code:

NCT06239194

Conditions

Biliary Tract Cancer

Breast Cancer

Cervical Cancer

Colon Cancer

Endometrial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MDX2001

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-08. This information was provided to ClinicalTrials.gov by ModeX Therapeutics, An OPKO Health Company on 2026-05-06.